FEEDBACK
PLEASE WAIT ...
CLOSE
Forgot password?
Create New Account
CLOSE
LOGIN
CREATE NEW ACCOUNT
menu
HOME
HOME
Refine
Refine
companies
companies
Statnano.com
Statnano.com
Contact us
Product Submission
GO
ADVANCED SEARCH
Home
Products
Epaxal®
Manufacturer
Crucell
Country
NETHERLANDS
Certificates
FDA
Registration Date
16 Nov 2016
Share
Epaxal®
(4)
Medicine
Pharmaceuticals
Product Number : 15747/0003
Hepatitis A Virus Antigen
Drug Information
Generic
Hepatitis A vaccine
NDC Code
15747/0003
Drug Class
Hepatitis A virus antigen (RG-SB strain)
Therapeutic Class
Vaccines, Antisera, and Immunologicals
Dosage form
Suspension
Route of Administration
intramuscular injection
Therapeutic Area
1.
Prevention of Hepatitis A infection
Indication
Active immunisation against hepatitis A of children from 1 year of age and adults
Benefit
Preventing hepatitis A in adults and children aged one year and over